InnovAge
INNV
$6.00
Share price
-1.15%
Change (1 day)
39.53%
Change (1 year)
Categories
Operating Margin for InnovAge (INNV)
Operating Margin as of September 2023 (TTM): -7.37%
According to InnovAge's latest financial reports and stock price the company's current Operating Margin is -7.37%. At the end of 2022 the company had an Operating Margin of -1.04%.
Operating Margin history for InnovAge from 2020 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -1.04% | -81.11% |
| 2021 | -5.48% | -187.27% |
| 2020 | 6.28% | 15.22% |
| 2019 | 5.45% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Merck MRK | 27.73% | -476.26% | 🇺🇸 USA |
 Cocrystal Pharma
COCP | -478.64% | 6,394.44% | 🇺🇸 USA |
 AcelRx Pharmaceuticals
ACRX | 0.00% | N/A | 🇺🇸 USA |
 Horizon Therapeutics
HZNP | 14.06% | -290.77% | 🇮🇪 Ireland |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.